Subscribe

    Neal Bhatia, MD: Topical Therapies Pipeline

    Dr. Neal Bhatia reviews promising topical therapies in development, highlighting new mechanisms and formulations shaping the future of dermatologic care.

    Topics Covered:

    • Emerging topical therapies in dermatology
    • Novel mechanisms of action and ingredients
    • Future trends in topical treatment development
    • Pipeline highlights for inflammatory and chronic skin diseases

     

    Explore Related Resources:

    Topical Therapies for the Treatment of Atopic Dermatitis

    Evaluating Effective Topical Therapies for Atopic Dermatitis

    MORE COVERAGE FROM THE 2025 AAD INNOVATION ACADEMY MEETING

    Jennifer Hsiao, MD: Dual Biologic Management in Hidradenitis Suppurativa

    Dr. Jennifer Hsiao explores dual biologic therapy as a potential strategy for managing complex, treatment-resistant cases of hidradenitis suppurativa. Topics Covered: Dual biologic use in

    PLAY
    Julie Harper, MD: What’s New in Rosacea

    Dr. Harper discusses results from head-to-head studies comparing new and existing oral rosacea treatments and navigating the difficulties of treating neurogenic rosacea.

    PLAY
    Clive Maopang Liu, MD: Update on Topical Therapy for Psoriasis

    Dr. Liu discusses new and emerging topical therapies for psoriasis and the continued value of topical therapies in psoriasis treatment.

    PLAY
    Andrea Tesvich Murina, MD: Advancements in Oral Therapies for Psoriasis

    Dr. Andrea Murina discusses how oral therapies can serve as an effective entry point to systemic treatment for patients with psoriasis. Topics Covered: Role of

    PLAY
    Mark Lebwohl, MD: Special Factors to Consider in Elderly Patients with Psoriasis

    Dr. Mark Lebwohl outlines key considerations for treating psoriasis in elderly patients, including comorbidities, cancer risk, and treatment affordability. Topics Covered: Psoriasis management in older

    PLAY
    Steven Daniel Daveluy, MD, FAAD: AI Phenotyping of Hidradenitis Suppurativa

    Dr. Daveluy discusses an exciting new project to uncover insights into HS disease patterns through analysis with artificial intelligence.

    PLAY
    Nada Elbuluk, MD: Skin of Color Primer—Inflammatory Diseases

    Dr. Elbuluk discusses unique considerations pertaining to inflammatory skin diseases in patients with skin of color.

    PLAY
    Saakshi Khattri, MD: Psoriatic Arthritis Update

    Dr. Khattri discusses emerging psoriatic arthritis treatments on the horizon, including deucravacitinib, zasocitinib, and icotrokinra.

    PLAY
    James Song, MD, FAAD: Utility of IL-17 Inhibitors for Psoriatic Disease

    Dr. James Song reviews how IL-17 inhibitors can be especially effective in treating psoriatic arthritis, special-site psoriasis, and biologic-experienced patients. Topics Covered: IL-17 inhibitors in

    PLAY
    Jeffrey Cohen, MD, MPH: Treatment of Psoriasis in High-impact Sites

    Dr. Cohen discusses the best biologics for treating psoriasis of the scalp, intertriginous areas, genitals, nails, and palms and soles of the feet.

    PLAY
    Ashish Bhatia, MD: New Technologies in Dermatology

    Dr. Bhatia reviews exciting new developments in dermatology technology, including a full-body dermoscopic robot, autologous cell transplants for wound healing, and stem cell banking for

    PLAY

    The AAD © Brand and Content are created by the American Academy of Dermatology “All rights reserved.” Any reproduction or republication is strictly prohibited without prior authorization.

    The content of the 2025 AAD Innovation Academy Meeting (the “Content”) is copyrighted by the American Academy of Dermatology (“AAD”). The Works, JCADTV Coverage from the 2025 AAD Innovation Academy Meeting, are made up of coverage interviews and summaries and are created from the Content of the AAD under a license between the AAD and Matrix Medical Communications (“MATRIX MEDICAL COMMUNICATIONS”), and MATRIX MEDICAL COMMUNICATIONS is solely responsible for their content. The license of any content by the AAD does not constitute or imply endorsement of any company or its goods, services, or written work products, and the AAD is not responsible for any errors or omissions in the translation or reproduction of the content.

    JCAD

    Journal of Clinical and Aesthetic Dermatology

    Facebook-f X-twitter Instagram Linkedin Youtube Spotify

    ©2026 JCAD | The Journal of Clinical and Aesthetic Dermatology. All Rights Reserved.